We assessed how CRC risk is influenced by PRS and carrier status for PV in high penetrant CRC susceptibility genes (APC, MLH1, MSH2, MSH6, PMS2) by calculating the ORs for CRC across groups compared to non-carriers with intermediate PRS as reference group. This evidence concerns the gene MSH2 and colorectal carcinoma.